Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
For the treatment policy estimate, missing data were imputed using outcomes from participants who discontinued treatment but completed the week 26 visit [1]
Considering that all of the patients had underlying diseases such as inflammatory bowel disease, colon cancer, and chronic cholecystitis, and that they had all undergone the trauma of surgery and bowel manipulation, the probability that BT exists in the absence of disease or trauma is low
Subacute combined cord degeneration: a rare complication of nitrous oxide misuse
Technological Breakthroughs: Three Innovation Paths Small-Molecule Drugs: Allosteric and Covalent Inhibitors Gain Momentum Small-molecule drugs continued to dominate approvals by volume, but the 2025 data tell a different story on innovation
Waegeman H, Soetaert W
US$ 29.47
US$ 28.04
US$ 22.76
US$ 22.25
US$ 22.15
